Characterizing Pediatric Tuberculosis with and without Human Immunodeficiency Virus Coinfection in Harare, Zimbabwe
Michelle Earley1, Joconiah Chirenda2, Alexandra Highet3
1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Insights
Pediatric tuberculosis (TB) and HIV coinfection significantly impact children in high-burden areas. Targeted interventions are crucial for reducing child mortality from TB and HIV.
Area of Science:
- Global Health
- Pediatric Infectious Diseases
- Epidemiology
Background:
- Pediatric tuberculosis (TB) is a major obstacle to reducing global TB mortality, particularly in regions with co-occurring TB and HIV epidemics.
- Limited epidemiological data exists for pediatric TB in high-burden settings, hindering targeted research and interventions.
Purpose of the Study:
- To characterize the epidemiology of pediatric TB in Harare, Zimbabwe, a high-burden setting.
- To identify predictors of HIV coinfection among pediatric TB cases.
Main Methods:
- Analysis of de-identified data from 1,051 pediatric TB cases (ages 0-14) out of 11,607 total TB cases reported in Harare, Zimbabwe (2011-2012).
- Utilized Pearson's chi-squared test and multivariate logistic regression to analyze epidemiological characteristics and HIV coinfection predictors.
Main Results:
- Pediatric TB constituted 9.1% of all reported TB cases; 50% of pediatric cases were under 5 years old.
- The overall HIV coinfection rate was 58.3%, with higher odds in older children (5-14 years), retreatment cases, and pulmonary TB.
- Observed distinct gender distribution patterns across different pediatric age groups.
Conclusions:
- Pediatric TB, exacerbated by HIV coinfection, poses a significant public health challenge in high-burden settings.
- Findings underscore the urgent necessity for tailored interventions and further research to address pediatric TB and HIV coinfection.
Abstract:
Pediatric tuberculosis (TB) represents a major barrier to reducing global TB mortality, especially in countries confronting dual TB and human immunodeficiency virus (HIV) epidemics. Our study aimed to characterize pediatric TB epidemiology in the high-burden setting of Harare, Zimbabwe, both to fill the current knowledge gap around the epidemiology of pediatric TB and to indicate areas for future research and interventions. We analyzed de-identified data of 1,051 pediatric TB cases (0-14 years) found among a total of 11,607 TB cases reported in Harare, Zimbabwe, during 2011-2012. We performed Pearson's χ2 test and multivariate logistic regression analysis to characterize pediatric TB and to assess predictors of HIV coinfection. Pediatric TB cases accounted for 9.1% of all TB cases reported during 2011-2012. Approximately 50% of pediatric TB cases were children younger than 5 years. Almost 60% of the under-5 age group were male, whereas almost 60% of the 10-14 age group were female. The overall HIV coinfection rate was 58.3%. Odds for HIV coinfection was higher for the 5-9 age group (adjusted odds ratio [AOR]: 2.77, 95% confidence interval [CI]: 1.97-3.94), the 10-14 group (AOR: 3.57, 95% CI: 2.52-5.11), retreatment cases (AOR: 6.17, 95% CI: 2.13, 26.16), and pulmonary TB cases (AOR: 2.39, 95% CI: 1.52, 3.75). In conclusion, our study generated evidence that pediatric TB, compounded by HIV coinfection, significantly impacts children in high-burden settings. The findings of our study indicate a critical need for targeted interventions.
More Related Videos
11:14Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
11:19Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
What are Viruses?
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pharmacokinetics in Pediatric Patients: Drug Excretion
